5-(naphthalen-2-yl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

6-BROMO-8-(TRIFLUOROMETHYL)-2H,3H-[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-ONE, 95%, 100mg

(5-Acetylpyridin-3-yl)boronic acid, 95%, 1g

1-(4-Bromophenyl)pyrrolidin-2-one, 95.0%, 25g

rel-(1R,4R)-4-(4-(Cyclopropylmethyl)piperazin-1-yl)cyclohexan-1-amine tris(4-methylbenzenesulfonate), 98%, 100mg

ethyl 3-{[2-(1H-indol-3-yl)ethyl]amino}propanoate, 95.0%, 2g

Indole-3-carbinol, 97.00%, 5g

3-AMINO-CYCLOBUTANEMETHANOL, 95.0%, 250mg

(3aR,5R,6R,6aR)-5-(Hydroxymethyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol, 98%, 5g

2-Chloroaniline, >=98%, pour la synthèse, 2,5 L, emballage en verre

(4-(Difluoromethyl)-2-oxabicyclo[2.1.1]hexan-1-yl)methanol, 98%, 1g

Fmoc-Glu-OtBu>98.0%(HPLC)(T)5g

2-chloro-6-(1H-imidazol-1-yl)pyridine, 95.0%, 500mg